Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 72
Filtrar
1.
J Prev Alzheimers Dis ; 3(3): 145-150, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-29205253

RESUMEN

BACKGROUND: In older adults declines in gait speed have been identified as predictors of functional decline and have been found in those with cognitive dysfunction. Cognitive training interventions that emphasize addressing executive function (EF) have resulted in a transfer effect from training cognitive processes into improved function. However research examining the effects of an EF specific computerized cognitive training (CCT) program on gait speed (GS) is limited. OBJECTIVES: To compare the effects of a six week EF specific CCT program on GS in community dwelling older adults using a pretest/posttest experimental design with subgroup comparisons based on a cutoff GS of 1.0m/s. SETTING: Home based. PARTICIPANTS: Forty independent living older adults (>65 years) without diagnosed cognitive impairment participated in either the intervention or control groups. INTERVENTION: A six week long progressively challenging EF focused CCT program was performed at home. MEASUREMENTS: Demographic variables, cognitive function (Trail-Making Test Part B) and GS were measured at baseline at week 7. Between group comparisons were completed for the whole sample initially with subgroup comparisons performed based on participants' initial GS (Slow walkers: GS<1.0m/s; Fast Walkers: GS>1.0m/s). RESULTS: No differences in GS were found for the whole population, but subgroup analyses restricted to slow walkers demonstrated a statistically significant improvement in GS after 6 weeks of CCT (µ =0.33 m/s, p = 0.03). Other outcomes measures were not statistically different at posttest. CONCLUSIONS: Older adults who walk at speeds <1.0m/s may benefit from a progressively challenging CCT program when self-administered in the home.

2.
Rural Remote Health ; 13(2): 2138, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23331256

RESUMEN

INTRODUCTION: The purpose of this secondary data analysis was to characterize the Internet usage of rural veterans (n=201) who had either never enrolled, or had previously enrolled but not accessed, Veterans Affairs (VA) health services in at least 2 years. The VA Office of Rural Health (ORH)(ie part of the United States Government Department of Veterans Affairs) is a government agency with the mission to improve access and quality of care for enrolled rural and highly rural US veterans. The ORH seeks to use evidence-based policies and innovative practices to support the unique needs of enrolled veterans residing in geographically remote areas. These individuals represent a population considered to experience health disparities secondary to reduced health care access. METHODS: This study explored the role of the Internet in providing health information and information regarding VA services to rural Caucasian and African American veterans in the southeastern USA. African Americans were significantly younger (50.32 years, SD=13.50, range 22-85 years) than Caucasian rural veterans (58.50 years, SD=13.82, range 21-85 years). RESULTS: A small majority of veterans (n=107; 53.23%) reported 'going on-line to use the Internet or World Wide Web, or to send and receive e-mail'. Among Internet users, multivariate logistic regression showed that neither age nor race/ethnicity predicted using the Internet to access health information or information regarding VA services. CONCLUSION: In comparison with population norms, rural veterans displayed lower usage of the Internet; however, there were few practical age differences between young, middle-aged and older rural veterans in use of the Internet for seeking health information. These results suggest a tremendous potential for online outreach efforts to rural veterans seeking health information and information regarding VA services and benefits. The US Federal Government's VA Office of Rural Health is investing in technology-based services and will need to disseminate information regarding the availability of these services to rural veterans.


Asunto(s)
Promoción de la Salud/métodos , Servicios de Salud Rural , Veteranos , Alabama , Humanos , Internet
3.
Environ Pollut ; 158(5): 1857-69, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-19962801

RESUMEN

Long term trend analysis of bulk precipitation, throughfall and soil solution elemental fluxes from 12 years monitoring at 10 ICP Level II forest sites in the UK reveal coherent national chemical trends indicating recovery from sulphur deposition and acidification. Soil solution pH increased and sulphate and aluminium decreased at most sites. Trends in nitrogen were variable and dependant on its form. Dissolved organic nitrogen increased in bulk precipitation, throughfall and soil solution at most sites. Nitrate in soil solution declined at sites receiving high nitrogen deposition. Increase in soil dissolved organic carbon was detected - a response to pollution recovery, changes in soil temperature and/or increased microbial activity. An increase of sodium and chloride was evident - a possible result of more frequent storm events at exposed sites. The intensive and integrated nature of monitoring enables the relationships between climate/pollutant exposure and chemical/biological response in forestry to be explored.


Asunto(s)
Ecosistema , Contaminación Ambiental , Contaminantes del Suelo/análisis , Árboles/química , Nitrógeno/análisis , Lluvia , Azufre/análisis , Reino Unido
4.
Tob Control ; 14 Suppl 2: ii19-25, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16046697

RESUMEN

International covenants establish a role for governments in ensuring the conditions for human health and wellbeing, which has been recognised as a central human right. International trade agreements, conversely, prioritize the rights of corporations over health and human rights. International trade agreements are threatening existing tobacco control policies and restrict the possibility of implementing new controls. This situation is unrecognised by many tobacco control advocates in signatory nations, especially those in developing countries. Recent agreements on eliminating various trade restrictions, including those on tobacco, have expanded far beyond simply international movement of goods to include internal tobacco distribution regulations and intellectual property rules regulating advertising and labelling. Our analysis shows that to the extent trade agreements protect the tobacco industry, in itself a deadly enterprise, they erode human rights principles and contribute to ill health. The tobacco industry has used trade policy to undermine effective barriers to tobacco importation. Trade negotiations provide an unwarranted opportunity for the tobacco industry to assert its interests without public scrutiny. Trade agreements provide the industry with additional tools to obstruct control policies in both developed and developing countries and at every level. The health community should become involved in reversing these trends, and help promote additional measures to protect public health.


Asunto(s)
Comercio/legislación & jurisprudencia , Prevención del Hábito de Fumar , Industria del Tabaco , Derechos Humanos , Humanos , Cooperación Internacional
5.
Semin Oncol Nurs ; 17(1): 41-7, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11236364

RESUMEN

OBJECTIVES: To describe the rapidly evolving field of consumer health informatics (CHI), which is empowering the patient and the public. DATA SOURCES: Published articles, research studies, and government reports pertaining to interactive health communication and CHI. CONCLUSIONS: Application of CHI can provide information to patients and the public, promote self-care, enable informed decision-making, promote healthy behaviors, and promote peer information exchange and social support. Quality, research methodology, and accessibility must all be increased to ensure that CHI achieves its potential to improve the nation's health. IMPLICATIONS FOR NURSING PRACTICE: With the advent of the internet, the profusion of consumer health-related web sites, online support groups, and electronic patient-centered communications present new challenges for clinical practice. Health care providers have important roles in helping their patients as well as the public locate, assess, and interpret health information.


Asunto(s)
Seguridad de Productos para el Consumidor , Educación en Salud/organización & administración , Servicios de Información/organización & administración , Internet/organización & administración , Informática Médica/organización & administración , Predicción , Humanos , Sistemas en Línea/organización & administración , Atención Dirigida al Paciente , Proyectos de Investigación/normas , Autocuidado , Grupos de Autoayuda/organización & administración , Evaluación de la Tecnología Biomédica
6.
Antimicrob Agents Chemother ; 45(4): 1143-50, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11257028

RESUMEN

beta-Sulfonyl carboxamides have been proposed to serve as transition-state analogues of the beta-ketoacyl synthase reaction involved in fatty acid elongation. We tested the efficacy of N-octanesulfonylacetamide (OSA) as an inhibitor of fatty acid and mycolic acid biosynthesis in mycobacteria. Using the BACTEC radiometric growth system, we observed that OSA inhibits the growth of several species of slow-growing mycobacteria, including Mycobacterium tuberculosis (H37Rv and clinical isolates), the Mycobacterium avium complex (MAC), Mycobacterium bovis BCG, Mycobacterium kansasii, and others. Nearly all species and strains tested, including isoniazid and multidrug resistant isolates of M. tuberculosis, were susceptible to OSA, with MICs ranging from 6.25 to 12.5 microg/ml. Only three clinical isolates of M. tuberculosis (CSU93, OT2724, and 401296), MAC, and Mycobacterium paratuberculosis required an OSA MIC higher than 25.0 microg/ml. Rapid-growing mycobacterial species, such as Mycobacterium smegmatis, Mycobacterium fortuitum, and others, were not susceptible at concentrations of up to 100 microg/ml. A 2-dimensional thin-layer chromatography system showed that OSA treatment resulted in a significant decrease in all species of mycolic acids present in BCG. In contrast, mycolic acids in M. smegmatis were relatively unaffected following exposure to OSA. Other lipids, including polar and nonpolar extractable classes, were unchanged following exposure to OSA in both BCG and M. smegmatis. Transmission electron microscopy of OSA-treated BCG cells revealed a disruption in cell wall synthesis and incomplete septum formation. Our results indicate that OSA inhibits the growth of several species of mycobacteria, including both isoniazid-resistant and multidrug resistant strains of M. tuberculosis. This inhibition may be the result of OSA-mediated effects on mycolic acid synthesis in slow-growing mycobacteria or inhibition via an undescribed mechanism. Our results indicate that OSA may serve as a promising lead compound for future antituberculous drug development.


Asunto(s)
Acetamidas/farmacología , Alcanosulfonatos/farmacología , Antibacterianos/farmacología , Lípidos de la Membrana/biosíntesis , Mycobacterium/efectos de los fármacos , Ácidos Micólicos/metabolismo , Cromatografía en Capa Delgada , Pruebas de Sensibilidad Microbiana , Microscopía Electrónica , Mycobacterium/metabolismo , Mycobacterium bovis/efectos de los fármacos , Mycobacterium bovis/metabolismo , Mycobacterium bovis/ultraestructura , Mycobacterium smegmatis/efectos de los fármacos , Mycobacterium smegmatis/metabolismo , Mycobacterium tuberculosis/efectos de los fármacos , Tiofenos/farmacología
7.
Psychiatr Serv ; 52(3): 362-7, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11239106

RESUMEN

OBJECTIVE: Despite increased public screening, many individuals with depression remain undetected or untreated. This study explored the performance of an Internet-based program in screening for depression. METHODS: The Centers for Epidemiological Studies Depression (CES-D) scale was adapted as an online screening test. The program advised persons whose score indicated a high probability of depression to seek treatment and asked them to complete a survey of attitudes and preferences that could be printed and taken to a health professional. Responses were collected anonymously for epidemiologic research. Demographic characteristics of participants were compared with those of the U.S. population and participants in previous community screenings. The costs of the program were calculated. RESULTS: The CES-D scale was completed 24,479 times during the eight-month study period. The respondents' median age category was 30 to 45 years, and almost 30 percent were male; 58 percent (N=14,185) screened positive for depression, and fewer than half of those had never been treated for depression. The proportion of younger individuals was larger than in previous public screenings, but was still lower than that in the U.S. population. Our sample contained a lower proportion of minorities than the U.S. population (16.6 percent versus 28.3 percent). Sunk costs totaled $9,000, and additional marginal costs to maintain the system totaled $3,750. CONCLUSIONS: The Internet provides a continuously available, inexpensive, easily maintained platform to anonymously screen a large number of individuals from a broad geographic area. However, older adults and minorities may visit screening sites less frequently than other populations.


Asunto(s)
Actitud Frente a la Salud , Trastorno Depresivo/diagnóstico , Internet/estadística & datos numéricos , Tamizaje Masivo/métodos , Adolescente , Adulto , Trastorno Depresivo/epidemiología , Trastorno Depresivo/prevención & control , Diagnóstico por Computador/métodos , Diagnóstico por Computador/psicología , Etnicidad , Femenino , Humanos , Internet/economía , Masculino , Tamizaje Masivo/economía , Persona de Mediana Edad , Vigilancia de la Población/métodos , Probabilidad , Evaluación de Programas y Proyectos de Salud , Escalas de Valoración Psiquiátrica , Estados Unidos/epidemiología
9.
Proc AMIA Symp ; : 269-73, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11825193

RESUMEN

BACKGROUND: Although interest in Consumer Health Informatics (CHI) has increased, a consensus definition of CHI does not yet exist. PURPOSE: To conduct a hypothesis-generating survey of AMIA members regarding definition and research agenda for CHI. METHODS: We solicited participation among AMIA members in an Internet-based survey focusing on issues related to a definition of CHI. RESULTS: One hundred thirty-five AMIA members responded. Participants indicated a broad spectrum of topics important to CHI including "self-help for disease management" and "patient access to their own medical records." CHI research was felt to rely heavily on public health methods such as epidemiology and outcomes research, a paradigm shift from traditional medical informatics. Responses indicated a perceived lack of funding and need for further research in CHI. CONCLUSIONS: A working definition should emphasize the multidisciplinary nature of CHI, include consumer input into CHI design, and focus on public health approaches to evaluation.


Asunto(s)
Servicios de Información , Informática Médica , Participación de la Comunidad , Recolección de Datos , Educación en Salud , Humanos , Sociedades Médicas
10.
J Med Chem ; 43(17): 3304-14, 2000 Aug 24.
Artículo en Inglés | MEDLINE | ID: mdl-10966749

RESUMEN

Long-chain lipid envelopes are characteristic of mycobacteria such as those that cause tuberculosis and leprosy. Inhibition of fatty acid synthesis or elongation is a strategy demonstrated to be clinically effective against M. tuberculosis. A new class of compounds designed to inhibit the beta-ketoacyl synthase reaction of fatty acid synthesis has been developed. Of >30 compounds described, the most active were acetamides containing alkylsulfonyl substituents. Inhibitory activities were acutely sensitive to net charge, chain length, and degree of unsaturation. The most active compound 5 (alkyl = C(10)) contained a single methylene spacer between the sulfone and carboxamide and exhibited an MIC of 0.75-1.5 microg/mL, comparable to first-line antituberculosis drugs. These compounds are species-specific, exhibiting no significant activity against bacterial species other than M. tuberculosis and closely related strains. The synthesis, biological activity, and specificity of these compounds are described.


Asunto(s)
Amidas/síntesis química , Antituberculosos/síntesis química , Sulfonas/síntesis química , Amidas/química , Amidas/farmacología , Antituberculosos/química , Antituberculosos/farmacología , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/efectos de los fármacos , Relación Estructura-Actividad , Sulfonas/química , Sulfonas/farmacología
12.
J Pediatr ; 136(6): 789-94, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10839878

RESUMEN

BACKGROUND: Topical lidocaine 2.5% and prilocaine 2.5% (EMLA) is effective in decreasing the pain associated with minor procedures including immunization, although the effect on the antibody response to vaccine constituents has not been assessed. OBJECTIVE: To measure the antibody response to measles-mumps-rubella (MMR) vaccine, as well as pain reduction associated with the use of the EMLA patch. PARTICIPANTS AND SETTING: One hundred sixty healthy infants at least 12 months old undergoing their first MM immunization in an ambulatory setting. DESIGN AND INTERVENTIONS: Randomized, double-blind, controlled trial of EMLA patch (5%-1 g) or placebo before MMR immunization. Blood sampling before and 28 to 35 days after immunization. OUTCOME MEASURES: The primary outcome measure was the antibody response to measles by plaque reduction neutralization and to mumps and rubella by enzyme immunoassay. The secondary outcomes were pain scores by the Modified Behavioral Pain Scale and drug- and vaccine-associated adverse events. RESULTS: There was no difference in the antibody response between the EMLA- and placebo-treated groups. The response rates in the EMLA group were 89.7%, 88.3%, and 92.3% to measles, mumps, and rubella, respectively, compared with rates of 91.1%, 94.9%, and 93.7% in the placebo group (P >.05 for all comparisons). EMLA recipients had less pain after immunization (mean Modified Behavioral Pain Scale score increase 3.1 compared with 3.8; P =.043) and less irritability (16% compared with 31%; P =.040) than did placebo recipients. CONCLUSIONS: The EMLA patch has no adverse effect on the antibody response to MMR vaccine and significantly reduces the pain associated with the subcutaneous administration of the vaccine.


Asunto(s)
Anestésicos Combinados/administración & dosificación , Anestésicos Locales/administración & dosificación , Lidocaína/administración & dosificación , Vacuna Antisarampión/efectos adversos , Vacuna Antisarampión/inmunología , Vacuna contra la Parotiditis/efectos adversos , Vacuna contra la Parotiditis/inmunología , Dolor/etiología , Dolor/prevención & control , Prilocaína/administración & dosificación , Vacuna contra la Rubéola/efectos adversos , Vacuna contra la Rubéola/inmunología , Administración Tópica , Anticuerpos/sangre , Método Doble Ciego , Femenino , Humanos , Lactante , Inyecciones Subcutáneas , Masculino , Vacuna contra el Sarampión-Parotiditis-Rubéola , Vacunas Combinadas/efectos adversos , Vacunas Combinadas/inmunología
14.
Tob Control ; 7(3): 281-93, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9825424

RESUMEN

OBJECTIVE: To assess the feasibility of reducing tobacco-caused disease by gradually removing nicotine from cigarettes until they would not be effective causes of nicotine addiction. DATA SOURCES: Issues posed by such an approach, and potential solutions, were identified from analysis of literature published by the US Food and Drug Administration (FDA) in its 1996 Tobacco Rule, comments of the tobacco industry and other institutions and individuals on the rule, review of the reference lists of relevant journal articles, other government publications, and presentations made at scientific conferences. DATA SYNTHESIS: The role of nicotine in causing and sustaining tobacco use was evaluated to project the impact of a nicotine reduction strategy on initiation and maintenance of, and relapse to, tobacco use. A range of potential concerns and barriers was addressed, including the technical feasibility of reducing cigarette nicotine content to non-addictive levels, the possibility that compensatory smoking would reduce potential health benefits, and whether such an approach would foster illicit ("black market") tobacco sales. Education, treatment, and research needs to enable a nicotine reduction strategy were also addressed. The Council on Scientific Affairs came to the following conclusions: (a) gradually eliminating nicotine from cigarettes is technically feasible; (b) a nicotine reduction strategy holds great promise in preventing adolescent tobacco addiction and assisting the millions of current cigarette smokers in their efforts to quit using tobacco products; (c) potential problems such as compensatory over-smoking of denicotinised cigarettes and black market sales could be minimised by providing alternate forms of nicotine delivery with less or little risk to health, as part of expanded access to treatment; and (d) such a strategy would need to be accompanied by relevant research and increased efforts to educate consumers and health professionals about tobacco and health. CONCLUSIONS: The council recommends the following: (a) that cessation of tobacco use should be the goal for all tobacco users; (b) that the American Medical Association continue to support FDA authority over tobacco products, and FDA classification of nicotine as a drug and tobacco products as drug-delivery devices; (c) that research be encouraged on cigarette modifications that may result in less addicting cigarettes; (d) that the FDA require that the addictiveness of cigarettes be reduced within 5-10 years; (e) expanded surveillance to monitor trends in the use of tobacco products and other nicotine-containing products; (f) expanded access to smoking cessation treatment, and strengthening of the treatment infrastructure; and (g) more accurate labelling of tobacco products, including a more meaningful and understandable indication of nicotine content.


Asunto(s)
Conducta Adictiva/psicología , Nicotina/efectos adversos , Fumar/efectos adversos , Promoción de la Salud , Humanos , Recurrencia , Cese del Hábito de Fumar
15.
J Nucl Med ; 39(8): 1454-7, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9708528

RESUMEN

UNLABELLED: The purpose of this article is to review the potential role of nuclear medicine scanning, especially with 67Ga, in the presumptive diagnosis and clinical management of patients with renal parenchymal malacoplakia (RPMP), a rare disease associated with coliform bacterial infection of the kidney and characterized by chronic unresolving inflammatory infiltrates containing von Hansemann macrophages in the renal parenchyma. METHODS: Published cases of RPMP were collected from the archival literature by searching the MEDLINE database and by reviewing bibliographic references contained in articles on malacoplakia. Data on the clinical features and radiographic evaluation of patients with RPMP were extracted from the clinical case reports. RESULTS: Forty-three cases of RPMP published over the past 20 yr were identified. Ten of the 43 patients (23%) had 67Ga scanning as a component of their diagnostic evaluation. In all 10 patients, renal uptake of 67Ga was classified as intense. Two of those 10 patients had serial 67Ga scanning performed to assess response to antibiotic treatment; both patients exhibited decreased uptake or complete resolution of abnormal renal uptake over time, a finding also exhibited by our patient. CONCLUSION: Intense renal uptake of 67Ga, typically in the clinical setting of fever, progressive renal failure and nephromegaly, strongly supports a diagnosis of RPMP. In those patients receiving prolonged antimicrobial therapy for RPMP, resolution of abnormal 67Ga uptake over time may provide an objective endpoint for treatment.


Asunto(s)
Citratos , Radioisótopos de Galio , Galio , Enfermedades Renales/diagnóstico por imagen , Malacoplasia/diagnóstico por imagen , Radiofármacos , Antiinfecciosos/uso terapéutico , Ácido Ascórbico/uso terapéutico , Ciprofloxacina/uso terapéutico , Femenino , Humanos , Persona de Mediana Edad , Cintigrafía , Rifampin/uso terapéutico
16.
Am J Prev Med ; 14(4): 374-6, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9635089

RESUMEN

A resolution, introduced by the American College of Preventive Medicine at the 1996 American Medical Association (AMA) Annual Meeting, asked the AMA to recommend to physicians the use of the United States Preventive Services Task Force's Guide to Clinical Preventive Services, Second Edition. In response to that resolution, the AMA's Council on Scientific Affairs has reviewed and evaluated this publication. The recommendations of the Council on Scientific Affairs on the use of the Guide to Clinical Preventive Services, Second Edition, by clinicians and medical educators are included in this report. These recommendations were adopted as AMA Policy at the AMA Annual Meeting in June 1997.


Asunto(s)
Publicaciones Gubernamentales como Asunto , Servicios Preventivos de Salud , Guías como Asunto , Humanos , Servicios Preventivos de Salud/normas , Medicina Preventiva , Estados Unidos
17.
Prim Care ; 25(1): 123-35, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9469919

RESUMEN

Teenage tobacco use is an increasingly prevalent health problem in this country. Three thousand teenagers become regular smokers each day. This article reviews adolescent tobacco use and its health dangers; a brief-office intervention for tobacco cessation in adolescents is described.


Asunto(s)
Cese del Hábito de Fumar/métodos , Tabaquismo/prevención & control , Adolescente , Femenino , Humanos , Entrevista Psicológica/métodos , Masculino , Modelos Psicológicos , Motivación , Cese del Hábito de Fumar/psicología , Medio Social , Tabaquismo/complicaciones , Tabaquismo/epidemiología , Tabaquismo/psicología , Estados Unidos/epidemiología
18.
Am J Prev Med ; 14(1): 25-30, 1998 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9476833

RESUMEN

BACKGROUND: Transferring new information to practicing physicians is a complex and often faulty process. Effective transfer is a challenging goal that requires a strategy for reaching large numbers of physicians throughout the country in a short time. However, methods for disseminating preventive health techniques such as smoking cessation have not been well organized. Smoking is the single most important preventable cause of premature mortality, so dissemination of research-based smoking-cessation techniques to physicians' practices is a priority for the National Cancer Institute (NCI). METHODS: NCI recruited national, professional medical organizations to collaborate in disseminating smoking-cessation techniques. The goal was to co-sponsor 50 Train-the-Trainer (TT) seminars that would prepare 2,000 professionals as volunteers to instruct their colleagues in smoking-cessation techniques. NCI provided all materials, faculty (nine professionals), advance logistics, CME credits, and follow-up. The co-sponsor organizations helped develop the training plan, promoted training among their members, enrolled professionals to be trained, and made logistical arrangements for the training sites. RESULTS: During the 4 years of the program, NCI recruited 11 national organizations as co-sponsors; conducted 53 TT seminars in 22 states and Washington, DC; and trained 2,098 professionals as smoking-cessation trainers, who practice nationwide. The many lessons learned provide the basis for recommendations that can assist others who want to work with professional organizations. CONCLUSION: The National Cancer Institute demonstrated that national organizations of medical professionals can help to disseminate effectively a research-based smoking-cessation program. Twelve recommendations are presented to help others disseminate preventive health techniques nationwide.


Asunto(s)
Educación en Salud/organización & administración , Pautas de la Práctica en Medicina , Medicina Preventiva/organización & administración , Cese del Hábito de Fumar , Educación Médica Continua , Guías como Asunto , Humanos , Innovación Organizacional , Medicina Preventiva/educación , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Estados Unidos
19.
Blood ; 89(2): 680-7, 1997 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-9002972

RESUMEN

Erythropoietin (Epo) is the central regulator of red blood cell production and acts primarily by inducing proliferation and differentiation of erythroid progenitor cells. Because a sufficient supply of iron is a prerequisite for erythroid proliferation and hemoglobin synthesis, we have investigated whether Epo can regulate cellular iron metabolism. We present here a novel biologic function of Epo, namely as a potential modulator of cellular iron homeostasis. We show that, in human (K562) and murine erythroleukemic cells (MEL), Epo enhances the binding affinity of iron-regulatory protein (IRP)-1, the central regulator of cellular iron metabolism, to specific RNA stem-loop structures, known as iron-responsive elements (IREs). Activation of IRP-1 by Epo is associated with a marked increase in transferrin receptor (trf-rec) mRNA levels in K562 and MEL, enhanced cell surface expression of trf-recs, and increased uptake of iron into cells. These findings are in agreement with the well-established mechanism whereby high-affinity binding of IRPs to IREs stabilizes trf-rec mRNA by protecting it from degradation by a specific RNase. The effects of Epo on IRE-binding of IRPs were not observed in human myelomonocytic cells (THP-1), which indicates that this response to Epo is not a general mechanism observed in all cells but is likely to be erythroid-specific. Our results provide evidence for a direct functional connection between Epo biology and iron metabolism by which Epo increases iron uptake into erythroid progenitor cells via posttranscriptional induction of trf-rec expression. Our data suggest that sequential administration of Epo and iron might improve the response to Epo therapy in some anemias.


Asunto(s)
Eritropoyetina/farmacología , Proteínas Hierro-Azufre/metabolismo , Hierro/metabolismo , Leucemia Eritroblástica Aguda/metabolismo , Proteínas de Unión al ARN/metabolismo , Receptores de Transferrina/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Humanos , Proteína 1 Reguladora de Hierro , Proteínas Reguladoras del Hierro , Ratones , Transferrina/metabolismo , Células Tumorales Cultivadas , Regulación hacia Arriba/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...